GS-100 hi recombinant AAV9 vector a ni a, mihring NGLY1 gene a encode a ni. US Food and Drug Administration leh European Medicine Agency (EMA) te chuan Orphan Drug designation an pe a. He therapy hian kum 2021 khan FDA's rare paediatric disease designation a dawng a, nikum khan fast track designation a dawng bawk.